Medicus Pharma Ltd (NASDAQ:MDCX) | WebDisclosure

Basculer en Français

9473	Companies
185388	Keywords
117739	Articles
99272	Press releases

Home
Companies
Medicus Pharma Ltd

BRIEF

published on 12/01/2025 at 14:05, 3 days 18 hours ago

Medicus Pharma nomme Carolyn Bonner directrice financière et présidente

Développement Clinique Directeur Financier Médecine Skinject Carolyn Bonner
BRIEF

published on 12/01/2025 at 14:05, 3 days 18 hours ago

Medicus Pharma Appoints Carolyn Bonner as CFO and President

Chief Financial Officer Clinical Development Medicus Pharma Skinject Carolyn Bonner
PRESS RELEASE

published on 12/01/2025 at 14:00, 3 days 18 hours ago

Medicus Pharma Ltd. Appoints Carolyn Bonner as Chief Financial Officer in Addition to Her Role as President
Carolyn Bonner appointed CFO of Medicus Pharma Ltd. succeeding Jim Quinlan due to health reasons. Bonner to lead financial and operational aspects of the company. Medicus advances clinical programs and expands pipeline

Chief Financial Officer Medicus Pharma Ltd. Clinical Development Programs Carolyn Bonner Therapeutics Assets
BRIEF

published on 11/17/2025 at 13:35, 17 days 18 hours ago

Medicus Pharma sollicite l'approbation prioritaire de la FDA pour le traitement SkinJect

Essais Cliniques Médecine Thérapies Innovantes Traitement Du Cancer De La Peau Bon De Priorité FDA
BRIEF

published on 11/17/2025 at 13:35, 17 days 18 hours ago

Medicus Pharma Seeks FDA Priority Approval for SkinJect Treatment

Clinical Trials Innovative Therapeutics Medicus Pharma Skin Cancer Treatment FDA Priority Voucher
PRESS RELEASE

published on 11/17/2025 at 13:30, 17 days 18 hours ago

Medicus Pharma Ltd. Announces Filing of FDA Commissioner's National Priority Voucher Application (CNPV) for SKNJCT-003 to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin
Medicus Pharma Ltd. announces FDA Commissioner's national priority voucher application for Skinject (SKNJCT-003) D-MNA to non-invasively treat BCC aligning with public health priorities and rare-disease needs

Medicus Pharma Ltd. Skinject National Priority Voucher BCC Treatment FDA Commissioner
BRIEF

published on 11/14/2025 at 23:05, 20 days 9 hours ago

Développements de Medicus Pharma et résultats financiers du troisième trimestre 2025

Résultats Financiers Essais Cliniques Médecine Teverelix Skinject
BRIEF

published on 11/14/2025 at 23:05, 20 days 9 hours ago

Medicus Pharma's Developments and Q3 2025 Financials

Financial Results Clinical Trials Medicus Pharma Teverelix Skinject
PRESS RELEASE

published on 11/14/2025 at 23:00, 20 days 9 hours ago

Medicus Pharma Ltd. Provides Corporate Updates and Reports Third Quarter 2025 Financial Highlights
Medicus Pharma Ltd. announces financial results and advancements in clinical development programs for doxorubicin-containing microneedle array (D-MNA) and Teverelix, a next generation GnRH antagonist. Company highlights important corporate updates and collaborations

Collaborations Medicus Pharma Ltd. Teverelix Clinical Development Programs Doxorubicin
BRIEF

published on 11/13/2025 at 13:35, 21 days 18 hours ago

Medicus Pharma Expands BCC Clinical Study into UK

Clinical Study Regulatory Approvals UK Expansion Medicus Pharma Basal Cell Carcinoma

1 2 ... 4

Accesswire

Published on 12/05/2025 at 02:35, 5 hours 39 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 5 hours 44 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 7 hours 14 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 9 hours 9 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 9 hours 14 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 08:05, 9 minutes ago

Smartmi Unveils the Air Purifier 3: Powerful, Smart, and Stylish Air Care for Modern Homes
Published on 12/05/2025 at 08:01, 13 minutes ago

Original-Research: Warimpex Finanz- und Beteiligungsholding AG (von East Value Research GmbH ):
Published on 12/05/2025 at 08:01, 13 minutes ago

Custodian Property Income REIT plc: Interim results for the period ended 30 September 2025
Published on 12/05/2025 at 08:00, 14 minutes ago

Swiss Prime Site Solutions Investment Fund Commercial (SPSS IFC) approaches the 500-million mark ahead of listing
Published on 12/05/2025 at 08:00, 14 minutes ago

Le Swiss Prime Site Solutions Investment Fund Commercial (SPSS IFC) croît et est sur le point de franchir la barre des 500 millions

Les Echos

Published on 12/04/2025 at 18:14, 14 hours ago

Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 14 hours 14 minutes ago

Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 14 hours 14 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 14 hours 29 minutes ago

Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 14 hours 29 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL

View all LES ECHOS COMFI WIRE